You are here

  • Home
  • Archive
  • Volume 80, Issue Suppl 1
  • POS0017 IMC-1, A FIXED DOSE COMBINATION OF FAMCICLOVIR AND CELECOXIB, IMPROVES COMMON SYMPTOMS ASSOCIATED WITH FIBROMYALGIA IN ADDITION TO PAIN: POST HOC ANALYSIS OF A PHASE 2A TRIAL

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Poster Tours
Epidemiology and treatment of pain in RMDs
POS0017 IMC-1, A FIXED DOSE COMBINATION OF FAMCICLOVIR AND CELECOXIB, IMPROVES COMMON SYMPTOMS ASSOCIATED WITH FIBROMYALGIA IN ADDITION TO PAIN: POST HOC ANALYSIS OF A PHASE 2A TRIAL
Free

 

Online download statistics by month:

Online download statistics by month: May 2021 to July 2022

AbstractFullPdf
May 20214010
Jun 2021504
Jul 20211308
Aug 2021507
Sep 20213013
Oct 2021309027
Nov 2021247040
Dec 2021263020
Jan 202222805
Feb 202225309
Mar 202219208
Apr 202227207
May 2022290018
Jun 2022192010
Jul 202219302
Total24690188